Superficial Thrombophlebitis vs. Deep
Venous Thrombosis
Yes, medicinal leeches' salivary glands produce a powerful anticoagulant HIRUDIN and ANTI-INFLAMMATORY agents. Because of leeches' powerful biochemical secretion, both types of superficial thrombophlebitis, -- a common inflammatory-thrombotic disorder in the SMALL SAPHENOUS VEIN & the Great Saphenous Vein (GSV) -- and, also Deep Venous Thrombosis (DVT) – all these three conditions qualify for hirudotherapy.
Small Saphenous Vein (SSV) thrombus is not life threatening condition. However, if not treated right or at all, in many cases, later might affect the greater saphenous vein and superficial thrombophlebitis will sometimes progress into the Deep Venous Thrombosis.
If your doctor is not concern about your condition in early stage of superficial/ Small Saphenous Vein thrombus formation, please give us a call and make an appointment for initial consultation. The sooner you start hirudo-therapy the more benefits for you! Prevent and reduce the risk of complications!
Superficial Thrombophlebitis includes: Small Saphenous Vein (SSV) and
Great Saphenous Vein (GSV) Thrombus
-----------------------------------------------------------
Hirudotherapy is also used for cardiovascular diseases such as arterial hypertension, angina pectoris, myocardial infarction and post-infarction arteriosclerosis.
Since the early days of the 20th century, people have been using leeches to treat cardiovascular diseases because of the Hirudin enzyme in the leeches saliva, a substance which has systemic anticoagulative effects. A physician would usually prescribe the use of leeches for a person suffered from the post-stroke effects or post CHF, heart attack. Also, Hirudin stimulates segmental reflex mechanisms and this contributes to the treatment of cardiovascular diseases.
Leech therapy is effective against these diseases, including hypertension because of its ability to relieve the stagnation of the blood in the vessels. When a leech is applied over a certain area, the blood flow to that area will increase, leading to better circulation. In fact, due to the treatments provide in our offices 99% of all cases clients' overall condition has been improved significantly after leech therapy.
------------------------------------------------------------------
Cardiovascular disease (CVD), including heart disease and stroke, remains the leading cause of death in the United States despite improvements in prevention, detection, and treatment. CVD is no longer thought of as a disease that primarily affects men as they age. It is a killer of people in the prime of life, with more than half of all deaths occurring among women.
Cardiovascular diseases remain the leading cause of disability among working adults. Stroke alone accounts for the disability of more than a million Americans.
Cardiovascular Disease in New York State
Cardiovascular diseases are the leading causes of death in New York State, killing more than 70,000 residents each year. For every person who dies from a heart attack or angina, 18 people live with these conditions. For every person who dies from a stroke, seven people cope with the consequences of a non-fatal event. Many of these survivors are disabled and cannot lead productive lives. They also are at high risk for additional events. These numbers are increasing as the epidemic of heart disease and stroke continues.
From Department of Health, Information for a Healthy New York, 2008
Yes, medicinal leeches' salivary glands produce a powerful anticoagulant HIRUDIN and ANTI-INFLAMMATORY agents. Because of leeches' powerful biochemical secretion, both types of superficial thrombophlebitis, -- a common inflammatory-thrombotic disorder in the SMALL SAPHENOUS VEIN & the Great Saphenous Vein (GSV) -- and, also Deep Venous Thrombosis (DVT) – all these three conditions qualify for hirudotherapy.
Small Saphenous Vein (SSV) thrombus is not life threatening condition. However, if not treated right or at all, in many cases, later might affect the greater saphenous vein and superficial thrombophlebitis will sometimes progress into the Deep Venous Thrombosis.
If your doctor is not concern about your condition in early stage of superficial/ Small Saphenous Vein thrombus formation, please give us a call and make an appointment for initial consultation. The sooner you start hirudo-therapy the more benefits for you! Prevent and reduce the risk of complications!
Superficial Thrombophlebitis includes: Small Saphenous Vein (SSV) and
Great Saphenous Vein (GSV) Thrombus
-----------------------------------------------------------
Hirudotherapy is also used for cardiovascular diseases such as arterial hypertension, angina pectoris, myocardial infarction and post-infarction arteriosclerosis.
Since the early days of the 20th century, people have been using leeches to treat cardiovascular diseases because of the Hirudin enzyme in the leeches saliva, a substance which has systemic anticoagulative effects. A physician would usually prescribe the use of leeches for a person suffered from the post-stroke effects or post CHF, heart attack. Also, Hirudin stimulates segmental reflex mechanisms and this contributes to the treatment of cardiovascular diseases.
Leech therapy is effective against these diseases, including hypertension because of its ability to relieve the stagnation of the blood in the vessels. When a leech is applied over a certain area, the blood flow to that area will increase, leading to better circulation. In fact, due to the treatments provide in our offices 99% of all cases clients' overall condition has been improved significantly after leech therapy.
------------------------------------------------------------------
Cardiovascular disease (CVD), including heart disease and stroke, remains the leading cause of death in the United States despite improvements in prevention, detection, and treatment. CVD is no longer thought of as a disease that primarily affects men as they age. It is a killer of people in the prime of life, with more than half of all deaths occurring among women.
Cardiovascular diseases remain the leading cause of disability among working adults. Stroke alone accounts for the disability of more than a million Americans.
Cardiovascular Disease in New York State
Cardiovascular diseases are the leading causes of death in New York State, killing more than 70,000 residents each year. For every person who dies from a heart attack or angina, 18 people live with these conditions. For every person who dies from a stroke, seven people cope with the consequences of a non-fatal event. Many of these survivors are disabled and cannot lead productive lives. They also are at high risk for additional events. These numbers are increasing as the epidemic of heart disease and stroke continues.
From Department of Health, Information for a Healthy New York, 2008